ArticleFrontiers in pharmacology2026
An open-source framework for physiologically-based pharmacokinetic modeling of kinetics in the female reproductive tract.
Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The female reproductive tract (FRT) is underrepresented in Physiologically-Based Pharmacokinetic (PBPK) models, creating a critical gap for data-driven, female-specific decision-making. To address this gap, a PBPK model extension for the FRT organs was developed in PK-Sim/MoBi. Methods: Physiological parameters were derived from a review of data in the public domain. The extension module characterizes four tissue compartments (cervix, vagina, endometrium, and myometrium) and two fluid compartments (uterine and cervicovaginal fluids), and enables the prediction of FRT tissue and plasma concentrations for several routes of administration, including vaginal and intra-uterine. Results: The model's predictions for systemic and local drug administration of levonorgestrel and metronidazole were validated against clinical data, demonstrating that the module accurately captures pharmacokinetics across multiple routes of administration. Discussion: The module can easily be adopted for any PBPK model in the Open Systems Pharmacology Suite. This work makes an important contribution to better representing female physiology in PBPK models and has the potential to improve women's healthcare.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.